SCHEMBL15426445

SCHEMBL15426445

CCSc1ccccc1-c1nc2cc(C(C)(F)C(F)(F)F)ccc2n1C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.38
ALDH1A1 P00352 3/20 0.38
CYP1A2 P05177 1/20 0.38
HPGD P15428 1/20 0.38
AGPAT2 O15120 1/20 0.37
PDE2A O00408 3/20 0.35
PDE10A Q9Y233 2/20 0.35
CNR2 P34972 1/20 0.33
NPC1 O15118 5/20 0.33
ATM Q13315 2/20 0.33
MAPT P10636 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
MEN1 O00255 1/20 0.33
HCRTR1 O43613 1/20 0.33
TSHR P16473 1/20 0.33
CASP1 P29466 1/20 0.33
HTT P42858 1/20 0.33
CASP7 P55210 1/20 0.33
HBB P68871 1/20 0.33
KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15426440 0.91 PDE2A (0.35) KDM4EALDH1A1CYP1A2HPGDPDE2A
SCHEMBL9959573 0.90 KDM4E (0.38) KDM4EALDH1A1CYP1A2HPGDAGPAT2
SCHEMBL9959582 0.90 AGPAT2 (0.44) KDM4EALDH1A1CYP1A2HPGDAGPAT2
SCHEMBL9959388 0.81 PDE2A (0.35) KDM4EALDH1A1CYP1A2HPGDPDE2A
SCHEMBL15426338 0.81 NLRP3 (0.46) KDM4EALDH1A1CYP1A2HPGDAGPAT2
SCHEMBL16285478 0.80 PDE2A (0.34) KDM4EALDH1A1CYP1A2HPGDPDE2A
SCHEMBL15426449 0.78 PIK3CA (0.42) KDM4EALDH1A1CYP1A2HPGDAGPAT2
SCHEMBL15412348 0.77 PDE2A (0.46) KDM4EALDH1A1CYP1A2HPGDAGPAT2
SCHEMBL166988 0.76 AGPAT2 (0.42) KDM4EALDH1A1HPGDAGPAT2PDE2A
SCHEMBL15868310 0.75 NPC1 (0.35) KDM4EAGPAT2PDE2APDE10ACNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9278983-B2 Fused heterocyclic compound and use thereof for pest control SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2016-03-08 US disclosed
US-20140364444-A1 FUSED HETEROCYCLIC COMPOUND AND USE THEREOF FOR PEST CONTROL SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2014-12-11 US disclosed
US-8853238-B2 Fused heterocyclic compound and use thereof for pest control SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2014-10-07 US disclosed
US-20140018373-A1 FUSED HETEROCYCLIC COMPOUND AND USE FOR PEST CONTROL THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2014-01-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140018373-A1 FUSED HETEROCYCLIC COMPOUND AND USE FOR PEST CONTROL THEREOF NR4A1, NR2C2, NR0B1 KDM4E 2981/4885ALDH1A1 3178/4885CYP1A2 210/4885
US-20140364444-A1 FUSED HETEROCYCLIC COMPOUND AND USE THEREOF FOR PEST CONTROL NR4A1, NR2C2, NR0B1 KDM4E 2968/4885ALDH1A1 3047/4885CYP1A2 202/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.